BRCA2 and small cell lung carcinoma: This is noteworthy as NCI‐H1048 cells were ~10‐fold more sensitive to DNA‐damaging agents (lurbinectedin and topotecan) as compared to other SCLC cell lines tested and displayed low BRCA2 expression indicating this line may be HR deficient or have reduced HR competency.